JNJ Stock: Johnson & Johnson Stock Price, Analysis & Insights
Get live JNJ stock price $226.71, comprehensive Johnson & Johnson stock analysis, charts, news, and expert forecast. Real-time JNJ stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its ...
Company Information
- CEO
- Joaquin Duato
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 138100
Contact Information
- Website
- https://www.jnj.com
- Address
- One Johnson & Johnson Plaza
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 545.7 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 26.2)
✓ Lower volatility stock (Beta: 0.26) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Johnson & Johnson shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Johnson & Johnson
- ⚠Investors should consider how Johnson & Johnson fits within their overall portfolio allocation
Market Cap
545.74B
P/E Ratio (TTM)
26.24
Beta
0.26
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Healthcare Stocks
Compare JNJ with:
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.